135 related articles for article (PubMed ID: 32106940)
1. The identification of synthetic cannabinoids surface coated on herbal substrates using solid-state nuclear magnetic resonance spectroscopy.
Burns NK; Theakstone AG; Zhu H; O'Dell LA; Pearson JR; Ashton TD; Pfeffer FM; Conlan XA
Anal Chim Acta; 2020 Apr; 1104():105-109. PubMed ID: 32106940
[TBL] [Abstract][Full Text] [Related]
2. Rapid identification of synthetic cannabinoids in herbal samples via direct analysis in real time mass spectrometry.
Musah RA; Domin MA; Walling MA; Shepard JR
Rapid Commun Mass Spectrom; 2012 May; 26(9):1109-14. PubMed ID: 22467461
[TBL] [Abstract][Full Text] [Related]
3. Use of SPME-HS-GC-MS for the analysis of herbal products containing synthetic cannabinoids.
Cox AO; Daw RC; Mason MD; Grabenauer M; Pande PG; Davis KH; Wiley JL; Stout PR; Thomas BF; Huffman JW
J Anal Toxicol; 2012 Jun; 36(5):293-302. PubMed ID: 22582264
[TBL] [Abstract][Full Text] [Related]
4. Direct analysis in real time mass spectrometry with collision-induced dissociation for structural analysis of synthetic cannabinoids.
Musah RA; Domin MA; Cody RB; Lesiak AD; Dane AJ; Shepard JR
Rapid Commun Mass Spectrom; 2012 Oct; 26(19):2335-42. PubMed ID: 22956326
[TBL] [Abstract][Full Text] [Related]
5. Review of detection frequency and type of synthetic cannabinoids in herbal compounds analyzed by Istanbul Narcotic Department of the Council of Forensic Medicine, Turkey.
Gurdal F; Asirdizer M; Aker RG; Korkut S; Gocer Y; Kucukibrahimoglu EE; Ince CH
J Forensic Leg Med; 2013 Aug; 20(6):667-72. PubMed ID: 23910858
[TBL] [Abstract][Full Text] [Related]
6. Identification and quantification of 10 indole/indazole carboxamide synthetic cannabinoids in 36 herbal blends by gas chromatography-mass spectrometry and nuclear magnetic resonance spectroscopy.
Liu CM; Jia W; Meng X; Hua ZD
J Forensic Sci; 2021 Nov; 66(6):2156-2166. PubMed ID: 34431514
[TBL] [Abstract][Full Text] [Related]
7. Prediction of designer drugs: synthesis and spectroscopic analysis of synthetic cannabinoid analogues of 1H-indol-3-yl(2,2,3,3-tetramethylcyclopropyl)methanone and 1H-indol-3-yl(adamantan-1-yl)methanone.
Carlsson A; Lindberg S; Wu X; Dunne S; Josefsson M; Åstot C; Dahlén J
Drug Test Anal; 2016 Oct; 8(10):1015-1029. PubMed ID: 26526273
[TBL] [Abstract][Full Text] [Related]
8. Identification of Eight Synthetic Cannabinoids, Including 5F-AKB48 in Seized Herbal Products Using DART-TOF-MS and LC-QTOF-MS as Nontargeted Screening Methods.
Moore KN; Garvin D; Thomas BF; Grabenauer M
J Forensic Sci; 2017 Sep; 62(5):1151-1158. PubMed ID: 28597943
[TBL] [Abstract][Full Text] [Related]
9. 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs?
Auwärter V; Dresen S; Weinmann W; Müller M; Pütz M; Ferreirós N
J Mass Spectrom; 2009 May; 44(5):832-7. PubMed ID: 19189348
[No Abstract] [Full Text] [Related]
10. Highly sensitive screening and analytical characterization of synthetic cannabinoids in nine different herbal mixtures.
Alves VL; Gonçalves JL; Aguiar J; Caldeira MJ; Teixeira HM; Câmara JS
Anal Bioanal Chem; 2021 Mar; 413(8):2257-2273. PubMed ID: 33575815
[TBL] [Abstract][Full Text] [Related]
11. DNA sequence analyses of blended herbal products including synthetic cannabinoids as designer drugs.
Ogata J; Uchiyama N; Kikura-Hanajiri R; Goda Y
Forensic Sci Int; 2013 Apr; 227(1-3):33-41. PubMed ID: 23092848
[TBL] [Abstract][Full Text] [Related]
12. Characterization of four new designer drugs, 5-chloro-NNEI, NNEI indazole analog, α-PHPP and α-POP, with 11 newly distributed designer drugs in illegal products.
Uchiyama N; Matsuda S; Kawamura M; Shimokawa Y; Kikura-Hanajiri R; Aritake K; Urade Y; Goda Y
Forensic Sci Int; 2014 Oct; 243():1-13. PubMed ID: 24769262
[TBL] [Abstract][Full Text] [Related]
13. Identification of a cannabinoid analog as a new type of designer drug in a herbal product.
Uchiyama N; Kikura-Hanajiri R; Kawahara N; Haishima Y; Goda Y
Chem Pharm Bull (Tokyo); 2009 Apr; 57(4):439-41. PubMed ID: 19336947
[TBL] [Abstract][Full Text] [Related]
14. Determination and identification of synthetic cannabinoids and their metabolites in different matrices by modern analytical techniques - a review.
Znaleziona J; Ginterová P; Petr J; Ondra P; Válka I; Ševčík J; Chrastina J; Maier V
Anal Chim Acta; 2015 May; 874():11-25. PubMed ID: 25910441
[TBL] [Abstract][Full Text] [Related]
15. Screening of "spice" herbal mixtures: From high-field to low-field proton NMR.
Assemat G; Dubocq F; Balayssac S; Lamoureux C; Malet-Martino M; Gilard V
Forensic Sci Int; 2017 Oct; 279():88-95. PubMed ID: 28854352
[TBL] [Abstract][Full Text] [Related]
16. Comments on "Characterization of four new designer drugs, 5-chloro-NNEI, NNEI indazole analog, α-PHPP and α-POP, with 11 newly distributed designer drugs in illegal products".
Tsujikawa K; Iwata YT; Inoue M; Higashibayashi S; Inoue H
Forensic Sci Int; 2015 Jun; 251():e15-7. PubMed ID: 25911381
[No Abstract] [Full Text] [Related]
17. Synthetic cannabinoids: analysis and metabolites.
Elsohly MA; Gul W; Wanas AS; Radwan MM
Life Sci; 2014 Feb; 97(1):78-90. PubMed ID: 24412391
[TBL] [Abstract][Full Text] [Related]
18. Identification and quantification of synthetic cannabinoids in 'spice-like' herbal mixtures: a snapshot of the German situation in the autumn of 2012.
Langer N; Lindigkeit R; Schiebel HM; Ernst L; Beuerle T
Drug Test Anal; 2014; 6(1-2):59-71. PubMed ID: 23723183
[TBL] [Abstract][Full Text] [Related]
19. Identification and structural characterization of the synthetic cannabinoid 3-(1-adamantoyl)-1-pentylindole as an additive in 'herbal incense'.
Kneisel S; Westphal F; Bisel P; Brecht V; Broecker S; Auwärter V
J Mass Spectrom; 2012 Feb; 47(2):195-200. PubMed ID: 22359329
[TBL] [Abstract][Full Text] [Related]
20. CBL-2201. Report on a new designer drug: Napht-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate.
Kondrasenko AA; Goncharov EV; Dugaev KP; Rubaylo AI
Forensic Sci Int; 2015 Dec; 257():209-213. PubMed ID: 26386336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
